Charles S. Fuchs, MD, MPH, is Director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, Professor of Medicine at Harvard Medical School and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer. He leads the Dana-Farber/Harvard Cancer Center Gastrointestinal Malignancies Program and the DF/HCC SPORE Grant in Gastrointestinal Cancers.
Dr. Fuchs splits his time between laboratory-based research, clinical research, and clinical care. His laboratory focuses on biochemical markers of GI cancer risk, molecular predictors of patient prognosis in colorectal and pancreatic cancers, and the discovery of novel targets for therapy. Dr. Fuchs is a member of the Scientific Advisory Board for the Lustgarten Foundation for Pancreatic Cancer and a cadre member of GI Committee for Cancer and Leukemia Group B. Dr. Fuchs has over 400 scientific publications in such journals as The New England Journal of Medicine, Lancet, Journal of the American Medical Association, Journal of Clinical Oncology, Cell, and Nature. Dr. Fuchs is the recipient of the Lee M. Nadler “Extra Mile” Award and the Tisch Award for Outstanding Achievement in Clinical Research, both at Dana-Farber.
Dr. Fuchs is a graduate of Harvard Medical School and completed his residency training at Brigham and Women’s Hospital. He completed a medical oncology fellowship at Dana-Farber.